However, scRNA+TCRαβ-seq data from HLA-A*02:01 + CML patients showed how the anti-PR1 T cell profile is highly cytotoxic in a patient who maintained the TFR, but larger study cohorts are needed to confirm these results. The gene discussed is HLA-A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.